RESOURCES FOR GUIDELINE-DRIVEN PrEP SCREENING
Pre-exposure prophylaxis (PrEP), in combination with safe sex practices, reduces the chance of being infected with HIV for individuals at risk.1 To maximize PrEP’s preventive benefits, it is crucial to follow CDC screening guidelines, which include regular HIV testing, among other tests.2 At Labcorp, we offer the latest CDC-compliant PrEP baseline and monitoring panels for oral and injectable PrEP, helping you minimize unnecessary out-of-pocket costs so you can focus on what matters most: your patients.
Whether your patients are initiating PrEP medication for the first time, reinitiating after a long stop, have recently taken PrEP or have been taking the medication for years, the CDC recommends routine testing to help prevent HIV infection.3
This includes persons who have had anal or vaginal sex in the past 6 months AND any of the following: an HIV-positive sexual partner, a bacterial STI in the past 6 months, or a history of inconsistent or no condom use with sexual partners.
This includes persons sharing injection equipment or having an HIV-positive injecting partner.